Trial intelligence / Profile preview

Drotaverine plus lornoxicam for acute renal colic

ChiCTR2000039501Phase 4Recruiting

Sponsor
Shandong Provincial Third Hospital
Start
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of drotaverine in Renal colic (3 arms), sponsored by Shandong Provincial Third Hospital. Primary endpoint: Pain score. Started Aug 2020; status: recruiting.

02

Drugs

drotaverine
03

Conditions

Renal colic

Beyond the preview

Go deeper on ChiCTR2000039501.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000039501.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call